,ID,Name,PharmaActions,InChIKey
0,19665,Butylhydroxybutylnitrosamine,,DIKPQFXYECAYPC-UHFFFAOYSA-N
1,2370,Bethanechol,Neurotransmitter Agents;Autonomic Agents;Molecular Mechanisms of Pharmacological Action;Muscarinic Agonists;Parasympathomimetics;Chemical Actions and Uses;Cholinergic Agents;Physiological Effects of Drugs;Pharmacologic Actions;Cholinergic Agonists;Peripheral Nervous System Agents,NZUPCNDJBJXXRF-UHFFFAOYSA-O
2,,,,
3,242065,4'-chloroflavanone,,WPHGNXFETYBHNT-UHFFFAOYSA-N
4,87279306,,,AVXZEYRIVAMKNG-PQZOIKATSA-N
5,5281800,acteoside,"Antioxidants;Specialty Uses of Chemicals;Antineoplastic Agents, Phytogenic;Anti-Infective Agents;Pharmacologic Actions;Physiological Effects of Drugs;Antineoplastic Agents;Therapeutic Uses;Chelating Agents;Chemical Actions and Uses;Sequestering Agents;Protective Agents;Immunologic Factors;Molecular Mechanisms of Pharmacological Action;Immunosuppressive Agents",FBSKJMQYURKNSU-ZLSOWSIRSA-N
6,2349,Penicillins,Chemical Actions and Uses;Anti-Infective Agents;Anti-Bacterial Agents;Pharmacologic Actions;Therapeutic Uses,JGSARLDLIJGVTE-UHFFFAOYSA-N
7,5476815,,,VWEYNEFKXXWVHZ-RSPUIOJXSA-N
8,10255,Kainic Acid,Antinematodal Agents;Physiological Effects of Drugs;Anthelmintics;Anti-Infective Agents;Chemical Actions and Uses;Therapeutic Uses;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Agents;Antiparasitic Agents;Pharmacologic Actions;Neurotransmitter Agents,VLSMHEGGTFMBBZ-OOZYFLPDSA-N
9,12699,Methylnitrosourea,Alkylating Agents;Noxae;Pharmacologic Actions;Toxic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,ZRKWMRDKSOPRRS-UHFFFAOYSA-N
10,5483658,,,FOUFFVYWFNBHHH-OIKIRKRFSA-N
11,27661,isosorbide-5-mononitrate,Chemical Actions and Uses;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Nitric Oxide Donors;Cardiovascular Agents;Vasodilator Agents;Pharmacologic Actions,YWXYYJSYQOXTPL-SLPGGIOYSA-N
12,400010,,,TXGZJQLMVSIZEI-UQMAOPSPSA-N
13,5578,Trimethoprim,"Antiparasitic Agents;Cytochrome P-450 Enzyme Inhibitors;Pharmacologic Actions;Anti-Dyskinesia Agents;Anti-Infective Agents, Urinary;Chemical Actions and Uses;Anti-Infective Agents;Antimalarials;Antiprotozoal Agents;Folic Acid Antagonists;Central Nervous System Agents;Therapeutic Uses;Cytochrome P-450 CYP2C8 Inhibitors;Renal Agents;Metabolic Side Effects of Drugs and Substances;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action",IEDVJHCEMCRBQM-UHFFFAOYSA-N
14,3150,,,VZFRNCSOCOPNDB-UHFFFAOYSA-N
15,4385592,"2-(2,3-dicarboxycyclopropyl)glycine",Central Nervous System Agents;Anticonvulsants;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions,MATPZHBYOVDBLI-UHFFFAOYSA-N
16,71562195,7-O-galloyltaxifolin,,KRMKNVIKYVHLTO-LEWJYISDSA-N
17,33032,Glutamic Acid,,WHUUTDBJXJRKMK-VKHMYHEASA-N
18,114739,"2,3-bis(3'-hydroxybenzyl)butyrolactone","Estrogens, Non-Steroidal;Physiological Effects of Drugs;Hormones, Hormone Substitutes, and Hormone Antagonists;Phytoestrogens;Pharmacologic Actions;Hormones;Chemical Actions and Uses;Estrogens",HVDGDHBAMCBBLR-PBHICJAKSA-N
19,24479,stannous chloride,,AXZWODMDQAVCJE-UHFFFAOYSA-L
20,1271,(alpha-carboxycyclopropyl)glycine,Chemical Actions and Uses;Excitatory Amino Acid Agents;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Physiological Effects of Drugs,GZOVEPYOCJWRFC-UHFFFAOYSA-N
21,57106630,,,XTWYTFMLZFPYCI-DGPXGRDGSA-N
22,4428,,,DQCKKXVULJGBQN-UHFFFAOYSA-N
23,9861304,YS 49,,YGCQFKVNIBDJFW-SFHVURJKSA-N
24,91690,tetcyclacis,,DPOWHSMECVNHAT-UHFFFAOYSA-N
25,9877229,bleomycin A6,,FOUFFVYWFNBHHH-YNGSZULRSA-N
26,3052762,prucalopride,Therapeutic Uses;Serotonin Agents;Laxatives;Gastrointestinal Agents;Serotonin Receptor Agonists;Chemical Actions and Uses;Neurotransmitter Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Serotonin 5-HT4 Receptor Agonists;Physiological Effects of Drugs,ZPMNHBXQOOVQJL-UHFFFAOYSA-N
27,24180710,,,DTNPNBFXGDHGPM-KKUQBAQOSA-N
28,123623,,,OGUJBRYAAJYXQP-CPYUAZPCSA-N
29,656486,,,YWRFBISQAMHSIX-UHFFFAOYSA-N
30,55480,,,XNCDYJFPRPDERF-PBCQUBLHSA-N
31,5273755,eupatilin,,DRRWBCNQOKKKOL-UHFFFAOYSA-N
32,5650,,,ACWBQPMHZXGDFX-UHFFFAOYSA-N
33,5282259,"10-nitro-9,12-octadecadienoic acid",,LELVHAQTWXTCLY-XYWKCAQWSA-N
34,5280353,Biliverdine,,RCNSAJSGRJSBKK-NSQVQWHSSA-N
35,4553,N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide,"Anti-Inflammatory Agents;Analgesics;Cyclooxygenase Inhibitors;Sensory System Agents;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Antirheumatic Agents;Analgesics, Non-Narcotic;Physiological Effects of Drugs;Anti-Inflammatory Agents, Non-Steroidal;Enzyme Inhibitors;Therapeutic Uses;Peripheral Nervous System Agents",KTDZCOWXCWUPEO-UHFFFAOYSA-N
36,1414,"12-hydroxy-5,8,10-heptadecatrienoic acid",,KUKJHGXXZWHSBG-UHFFFAOYSA-N
37,28536,4-hydroxyhexenal,,JYTUBIHWMKQZRB-UHFFFAOYSA-N
38,32800,,,IZTQOLKUZKXIRV-UHFFFAOYSA-N
39,558221,,,NAAJVHHFAXWBOK-UHFFFAOYSA-N
40,5311246,ONO 1301,,WBBLIRPKRKYMTD-UHFFFAOYSA-N
41,3816,,,VLSMHEGGTFMBBZ-UHFFFAOYSA-N
42,2518,,,QAIPRVGONGVQAS-UHFFFAOYSA-N
43,15491250,,,HSOKCKRDVRKPGT-UHFFFAOYSA-N
44,1232,1-hydroxy-3-amino-2-pyrrolidone,Excitatory Amino Acid Antagonists;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Agonists;Excitatory Amino Acid Agents;Physiological Effects of Drugs;Neurotransmitter Agents;Pharmacologic Actions,HCKUBNLZMKAEIN-UHFFFAOYSA-N
45,5497107,G(M1) Ganglioside,,QPJBWNIQKHGLAU-BVLUPYCXSA-N
46,42742,,,GKVUDAZMZLMNJQ-UHFFFAOYSA-N
47,9987061,,,BBAOHIALRKLBRD-OZDPOCAXSA-N
48,23915,schizandrin,,YEFOAORQXAOVJQ-UHFFFAOYSA-N
49,72886,,,XVOYSCVBGLVSOL-REOHCLBHSA-N
50,156418,Cinacalcet,"Calcium-Regulating Hormones and Agents;Physiological Effects of Drugs;Pharmacologic Actions;Hormones, Hormone Substitutes, and Hormone Antagonists;Calcimimetic Agents;Chemical Actions and Uses;Hormone Antagonists",QANQWUQOEJZMLL-PKLMIRHRSA-N
51,,,,
52,28417,Danazol,"Hormones, Hormone Substitutes, and Hormone Antagonists;Hormone Antagonists;Estrogen Antagonists;Physiological Effects of Drugs;Chemical Actions and Uses;Pharmacologic Actions",POZRVZJJTULAOH-LHZXLZLDSA-N
53,165390,methacrylyl-coenzyme A,,NPALUEYCDZWBOV-NDZSKPAWSA-N
54,245005,Aconitine,"Voltage-Gated Sodium Channel Agonists;Molecular Mechanisms of Pharmacological Action;Membrane Transport Modulators;Adjuvants, Immunologic;Sodium Channel Agonists;Physiological Effects of Drugs;Chemical Actions and Uses;Immunologic Factors;Pharmacologic Actions",XFSBVAOIAHNAPC-XTHSEXKGSA-N
55,83606,,,ONYCUIABXVBCTR-UHFFFAOYSA-N
56,2207,2-amino-4-phosphonobutyric acid,Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Therapeutic Uses;Neurotransmitter Agents;Anticonvulsants;Excitatory Amino Acid Agents;Central Nervous System Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Excitatory Amino Acid Agonists,DDOQBQRIEWHWBT-UHFFFAOYSA-N
57,124219,rubimaillin,,VLGATXOTCNBWIT-UHFFFAOYSA-N
58,3410,Formoterol Fumarate,Adrenergic Agonists;Autonomic Agents;Bronchodilator Agents;Adrenergic Agents;Adrenergic beta-2 Receptor Agonists;Anti-Asthmatic Agents;Physiological Effects of Drugs;Respiratory System Agents;Therapeutic Uses;Neurotransmitter Agents;Peripheral Nervous System Agents;Adrenergic beta-Agonists;Chemical Actions and Uses;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action,BPZSYCZIITTYBL-UHFFFAOYSA-N
59,16136245,acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide,,MEUCPCLKGZSHTA-XYAYPHGZSA-N
60,5280483,Vitamin K 1,Micronutrients;Pharmacologic Actions;Antifibrinolytic Agents;Physiological Effects of Drugs;Nutrients;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Growth Substances;Hemostatics;Vitamins;Therapeutic Uses;Fibrin Modulating Agents;Hematologic Agents;Coagulants,MBWXNTAXLNYFJB-LKUDQCMESA-N
61,449219,,,XKMGDFKROIEADD-CIOUUCGESA-N
62,11600642,"3,4-dihydroxyphenyllactic acid",,PAFLSMZLRSPALU-MRVPVSSYSA-N
63,73755113,tin protoporphyrin IX,Enzyme Inhibitors;Pharmacologic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,VWEYNEFKXXWVHZ-IBPJAKCHSA-N
64,5441,,,HXQVQGWHFRNKMS-UHFFFAOYSA-L
65,72429,leupeptin,Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Enzyme Inhibitors;Protease Inhibitors;Cysteine Proteinase Inhibitors;Chemical Actions and Uses,GDBQQVLCIARPGH-ULQDDVLXSA-N
66,105035,,,OSTGTTZJOCZWJG-UHFFFAOYSA-N
67,,,,
68,9834591,"4-aminho-2-thiabicyclo(3.1.0)hexane-4,6-dicarboxylic acid",,AVDUGNCTZRCAHH-MDASVERJSA-N
69,114778,kahweol,,JEKMKNDURXDJAD-HWUKTEKMSA-N
70,9808022,BAY 58-2667,,WPYWMXNXEZFMAK-UHFFFAOYSA-N
71,5589,,,DFBIRQPKNDILPW-UHFFFAOYSA-N
72,5282219,sofalcone,Gastrointestinal Agents;Therapeutic Uses;Anti-Ulcer Agents;Pharmacologic Actions;Chemical Actions and Uses,GFWRVVCDTLRWPK-KPKJPENVSA-N
73,5040205,"3,5-dihydroxy-4'-methoxystilbene",,IHVRWFJGOIWMGC-UHFFFAOYSA-N
74,8830,"2,4-dinitrofluorobenzene sulfonic acid",,YUXIBTJKHLUKBD-UHFFFAOYSA-N
75,73592,,,FBSKJMQYURKNSU-QJDQKFITSA-N
76,5626,"(5,6-dimethoxyindan-2-yl)dipropylamine",Dopamine Agents;Dopamine Antagonists;Physiological Effects of Drugs;Pharmacologic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents,UOLJKAPABHXFRE-UHFFFAOYSA-N
77,11698643,1-(3-(2-pyrrolidinylethoxy)phenyl)-3-((3-(trifluoromethyl)phenyl)azamethylene)benzo(d)azolin-2-one,,HXCJZIBJTFITNI-UHFFFAOYSA-N
78,54459,Idazoxan,Physiological Effects of Drugs;Chemical Actions and Uses;Neurotransmitter Agents;Adrenergic Agents;Adrenergic alpha-Antagonists;Pharmacologic Actions;Adrenergic Antagonists;Adrenergic alpha-2 Receptor Antagonists;Molecular Mechanisms of Pharmacological Action,HPMRFMKYPGXPEP-UHFFFAOYSA-N
79,16104907,subamolide B,,YLCXJNOKPGBEPM-DPBVHHOFSA-N
80,80309,alizarin 1-methyl ether,,VRGZEPNGEFBVIZ-UHFFFAOYSA-N
81,3180,dyclonine,"Anesthetics;Chemical Actions and Uses;Peripheral Nervous System Agents;Physiological Effects of Drugs;Pharmacologic Actions;Anesthetics, Local;Sensory System Agents;Central Nervous System Depressants;Central Nervous System Agents;Therapeutic Uses",BZEWSEKUUPWQDQ-UHFFFAOYSA-N
82,739,,,MSWZFWKMSRAUBD-UHFFFAOYSA-N
83,611,Glutamic Acid,,WHUUTDBJXJRKMK-UHFFFAOYSA-N
84,6169,Yohimbine,Adrenergic alpha-Antagonists;Peripheral Nervous System Agents;Physiological Effects of Drugs;Adrenergic Agents;Urological Agents;Autonomic Agents;Neurotransmitter Agents;Adrenergic Antagonists;Adrenergic alpha-2 Receptor Antagonists;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Therapeutic Uses;Mydriatics;Pharmacologic Actions,PIPZGJSEDRMUAW-VJDCAHTMSA-N
85,1894360,,,DTZDSNQYNPNCPK-UHFFFAOYSA-P
86,15139,fluanisone,Pharmacologic Actions;Tranquilizing Agents;Central Nervous System Agents;Hypnotics and Sedatives;Antipsychotic Agents;Central Nervous System Depressants;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Psychotropic Drugs,IRYFCWPNDIUQOW-UHFFFAOYSA-N
87,6918522,omtriptolide,,HROMYAWHLUOUPY-AHCCQAQQSA-N
88,5280506,prostaglandin F2beta,,PXGPLTODNUVGFL-JZFBHDEDSA-N
89,877,methacrylyl-coenzyme A,,NPALUEYCDZWBOV-UHFFFAOYSA-N
90,23982,Gadolinium,,UIWYJDYFSGRHKR-UHFFFAOYSA-N
91,3477,,,FIVPIPIDMRVLAY-UHFFFAOYSA-N
92,6053,p-Dimethylaminoazobenzene,Carcinogens;Noxae;Chemical Actions and Uses;Specialty Uses of Chemicals;Coloring Agents;Toxic Actions,JCYPECIVGRXBMO-UHFFFAOYSA-N
93,159508,CDRI 85-287,,DBHGMZQRJDUFGS-UHFFFAOYSA-N
94,11635,octadecane,,RZJRJXONCZWCBN-UHFFFAOYSA-N
95,135235,,,IAOQCZBMCCPRDU-UHFFFAOYSA-N
96,24846128,,,GZMJEZQPYGGHGJ-XIASAICYSA-N
97,3246569,,,QMLSMSICNBXNLJ-YUPRTTJUSA-N
98,892,scyllitol,,CDAISMWEOUEBRE-UHFFFAOYSA-N
99,16682999,bismuth subgallate,Hematologic Agents;Pharmacologic Actions;Hemostatics;Coagulants;Therapeutic Uses;Chemical Actions and Uses;Anti-Infective Agents,XXCBNHDMGIZPQF-UHFFFAOYSA-L
100,9815559,,,XRZWVSXEDRYQGC-ZJUUUORDSA-N
101,1233,Ibotenic Acid,Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Excitatory Amino Acid Agents;Pharmacologic Actions;Neurotransmitter Agents;Excitatory Amino Acid Agonists;Chemical Actions and Uses,IRJCBFDCFXCWGO-UHFFFAOYSA-N
102,,,,
103,40539,Quisqualic Acid,Neurotransmitter Agents;Excitatory Amino Acid Agents;Physiological Effects of Drugs;Excitatory Amino Acid Agonists;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses,ASNFTDCKZKHJSW-REOHCLBHSA-N
104,107992,6-chloro-2-(1-piperazinyl)pyrazine,Pharmacologic Actions;Neurotransmitter Agents;Serotonin Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Serotonin Receptor Agonists,CJAWPFJGFFNXQI-UHFFFAOYSA-N
105,11095,,,SBHXYTNGIZCORC-UHFFFAOYSA-N
106,1381,,,YBCDZAGHRGXDRX-UHFFFAOYSA-N
107,5976,dimazine,,RHUYHJGZWVXEHW-UHFFFAOYSA-N
108,11158353,"N-(2-(3-chloro-5-(trifluoromethyl)-2-pyridyl)ethyl)-alpha,alpha,alpha-trifluoro-o-toluamide",,KVDJTXBXMWJJEF-UHFFFAOYSA-N
109,9881506,4-methylene-2-octyl-5-oxofuran-3-carboxylic acid,,VCWLZDVWHQVAJU-NEPJUHHUSA-N
110,156288,,,MGOKSQNXXRPCMD-UHFFFAOYSA-N
111,73333,amperozide,Pharmacologic Actions;Chemical Actions and Uses;Neurotransmitter Agents;Central Nervous System Agents;Psychotropic Drugs;Therapeutic Uses;Physiological Effects of Drugs;Serotonin Antagonists;Antipsychotic Agents;Molecular Mechanisms of Pharmacological Action;Tranquilizing Agents;Central Nervous System Depressants;Serotonin Agents,NNAIYOXJNVGUOM-UHFFFAOYSA-N
112,3645619,N-((4-(2-cyanophenyl)-1-piperazinyl)methyl)-3-methylbenzamide,,DNULYRGWTFLJQL-UHFFFAOYSA-N
113,6360,,,NNPPMTNAJDCUHE-UHFFFAOYSA-N
114,19777023,,,LIEVTTYXDCZXRG-UHFFFAOYSA-N
115,5283314,4-hydroxyhexenal,,JYTUBIHWMKQZRB-ONEGZZNKSA-N
116,104742,,,HPZJMUBDEAMBFI-HSQYWUDLSA-N
117,115010,,,MSLKMRUEVOYOOZ-UHFFFAOYSA-L
118,10917,Carnitine,,PHIQHXFUZVPYII-ZCFIWIBFSA-N
119,5281654,3-methylquercetin,,IZQSVPBOUDKVDZ-UHFFFAOYSA-N
120,124062,rubiadin,,IRZTUXPRIUZXMP-UHFFFAOYSA-N
121,156665,eglumetad,Neurotransmitter Agents;Excitatory Amino Acid Agonists;Central Nervous System Agents;Tranquilizing Agents;Excitatory Amino Acid Agents;Central Nervous System Depressants;Pharmacologic Actions;Physiological Effects of Drugs;Molecular Mechanisms of Pharmacological Action;Psychotropic Drugs;Therapeutic Uses;Anti-Anxiety Agents;Chemical Actions and Uses,XJPQOSJARVVBIU-PLFKSMQJSA-N
122,2513,Cacodylic Acid,Agrochemicals;Specialty Uses of Chemicals;Toxic Actions;Pesticides;Herbicides;Chemical Actions and Uses,OGGXGZAMXPVRFZ-UHFFFAOYSA-N
123,56603730,,,UPSXYNJDCKOCFD-DEGUGSHBSA-N
124,56841897,microcystin,Pharmacologic Actions;Enzyme Inhibitors;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,SRUWWOSWHXIIIA-UKPGNTDSSA-N
125,2008,Aclarubicin,"Pharmacologic Actions;Topoisomerase II Inhibitors;Enzyme Inhibitors;Topoisomerase Inhibitors;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Antineoplastic Agents;Antibiotics, Antineoplastic;Therapeutic Uses",USZYSDMBJDPRIF-UHFFFAOYSA-N
126,179536,"3,4-dihydroxyphenyllactic acid",,PAFLSMZLRSPALU-QMMMGPOBSA-N
127,14584,fencamfamine,Central Nervous System Agents;Pharmacologic Actions;Tranquilizing Agents;Central Nervous System Stimulants;Therapeutic Uses;Psychotropic Drugs;Chemical Actions and Uses;Central Nervous System Depressants;Antipsychotic Agents;Physiological Effects of Drugs,IKFBPFGUINLYQI-UHFFFAOYSA-N
128,4850,Piribedil,Dopamine Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Central Nervous System Agents;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Anti-Dyskinesia Agents;Therapeutic Uses;Antiparkinson Agents;Dopamine Agonists,OQDPVLVUJFGPGQ-UHFFFAOYSA-N
129,115271,DDB,,YNPIDJWKKHGXAK-UHFFFAOYSA-N
130,9297,Allylisopropylacetamide,,HINLFAQOKAHXOD-UHFFFAOYSA-N
131,60809,xanomeline,Pharmacologic Actions;Chemical Actions and Uses;Therapeutic Uses;Cholinergic Agents;Cholinergic Agonists;Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Muscarinic Agonists;Autonomic Agents;Central Nervous System Agents;Psychotropic Drugs;Peripheral Nervous System Agents;Parasympathomimetics;Neurotransmitter Agents,JOLJIIDDOBNFHW-UHFFFAOYSA-N
132,5312765,"12-hydroxy-5,8,10-heptadecatrienoic acid",,KUKJHGXXZWHSBG-GMPNNLDHSA-N
133,100184,3'-deamino-3'-(3-cyano-4-morpholinyl)doxorubicin,"Therapeutic Uses;Laboratory Chemicals;Pharmacologic Actions;Indicators and Reagents;Antineoplastic Agents;Cross-Linking Reagents;Specialty Uses of Chemicals;Antibiotics, Antineoplastic;Chemical Actions and Uses",YIMDLWDNDGKDTJ-UHFFFAOYSA-N
134,3246390,cambinol,,RVNSQVIUFZVNAU-UHFFFAOYSA-N
135,11445168,,,ZDFOCDTXDPKJKA-UHFFFAOYSA-N
136,34040,Nicergoline,Physiological Effects of Drugs;Therapeutic Uses;Adrenergic alpha-Antagonists;Pharmacologic Actions;Central Nervous System Agents;Adrenergic Agents;Chemical Actions and Uses;Adrenergic Antagonists;Molecular Mechanisms of Pharmacological Action;Nootropic Agents;Vasodilator Agents;Neurotransmitter Agents;Cardiovascular Agents,YSEXMKHXIOCEJA-FVFQAYNVSA-N
137,2471,Bumetanide,Membrane Transport Modulators;Physiological Effects of Drugs;Chemical Actions and Uses;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Natriuretic Agents;Diuretics;Sodium Potassium Chloride Symporter Inhibitors,MAEIEVLCKWDQJH-UHFFFAOYSA-N
138,860,,,DTOSIQBPPRVQHS-UHFFFAOYSA-N
139,16131215,abarelix,"Pharmacologic Actions;Physiological Effects of Drugs;Hormone Antagonists;Chemical Actions and Uses;Hormones, Hormone Substitutes, and Hormone Antagonists",AIWRTTMUVOZGPW-HSPKUQOVSA-N
140,56841561,,,HROMYAWHLUOUPY-GOONNFATSA-N
141,3488,Glyburide,Chemical Actions and Uses;Hypoglycemic Agents;Pharmacologic Actions;Physiological Effects of Drugs,ZNNLBTZKUZBEKO-UHFFFAOYSA-N
142,35319,asperlin,,SPKNARKFCOPTSY-UHFFFAOYSA-N
143,24154,Galactosamine,,MSWZFWKMSRAUBD-GASJEMHNSA-N
144,71120,isospaglumic acid,Anti-Asthmatic Agents;Protective Agents;Molecular Mechanisms of Pharmacological Action;Histamine Agents;Anti-Allergic Agents;Peripheral Nervous System Agents;Neuroprotective Agents;Neurotransmitter Agents;Therapeutic Uses;Histamine Antagonists;Chemical Actions and Uses;Pharmacologic Actions;Central Nervous System Agents;Respiratory System Agents;Physiological Effects of Drugs;Histamine H1 Antagonists;Toxic Actions;Noxae;Autonomic Agents;Bronchodilator Agents;Neurotoxins,OPVPGKGADVGKTG-NKWVEPMBSA-N
145,20138,,,MLUCVPSAIODCQM-UHFFFAOYSA-N
146,5018,SCH 23390,,GOTMKOSCLKVOGG-UHFFFAOYSA-N
147,157350,,,TUJKJAMUKRIRHC-UHFFFAOYSA-N
148,104766,"1-amino-1,3-dicarboxycyclopentane",Central Nervous System Agents;Therapeutic Uses;Neuroprotective Agents;Chemical Actions and Uses;Protective Agents;Pharmacologic Actions;Physiological Effects of Drugs,YFYNOWXBIBKGHB-FBCQKBJTSA-N
149,9929731,"2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid",,GPCJDSXBRMKASP-UHFFFAOYSA-N
150,40828,diisopropanolnitrosamine,Carcinogens;Chemical Actions and Uses;Noxae;Mutagens;Toxic Actions,MNIGYIKCFSPQRJ-UHFFFAOYSA-N
151,5311181,Iloprost,Platelet Aggregation Inhibitors;Pharmacologic Actions;Vasodilator Agents;Cardiovascular Agents;Hematologic Agents;Chemical Actions and Uses;Therapeutic Uses,HIFJCPQKFCZDDL-ACWOEMLNSA-N
152,9825540,,,XCUWNMROWMXDLH-CKUXDGONSA-N
153,161784,abieslactone,,RHCAOVDBFCREAC-XOUPGTJXSA-N
154,6518,Pentaerythritol Tetranitrate,Chemical Actions and Uses;Therapeutic Uses;Cardiovascular Agents;Vasodilator Agents;Pharmacologic Actions,TZRXHJWUDPFEEY-UHFFFAOYSA-N
155,939,,,DAYLJWODMCOQEW-UHFFFAOYSA-O
156,442089,stevioside,Specialty Uses of Chemicals;Food Ingredients;Sweetening Agents;Flavoring Agents;Chemical Actions and Uses;Food Additives,UEDUENGHJMELGK-HYDKPPNVSA-N
157,9868580,biphenyl-indanone A,,KMKBEESNZAPKMP-UHFFFAOYSA-N
158,340211,latifolin,,OJVQOGDGFIJYPN-LLVKDONJSA-N
159,2937,"9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2",Therapeutic Uses;Chemical Actions and Uses;Antiviral Agents;Pharmacologic Actions;Antineoplastic Agents;Anti-Infective Agents,TUXFWOHFPFBNEJ-UHFFFAOYSA-N
160,59239114,,,WQBAZXIQANTUOY-KRWDZBQOSA-N
161,5310984,"4-aminopyrrolidine-2,4-dicarboxylic acid",,XZFMJVJDSYRWDQ-AWFVSMACSA-N
162,9804719,,,LNDPHUOSLCCHHY-PYJNHQTQSA-N
163,9963963,G(M1) Ganglioside,,QPJBWNIQKHGLAU-IQZHVAEDSA-N
164,108007,cobaltiprotoporphyrin,,AQTFKGDWFRRIHR-UHFFFAOYSA-L
165,637760,Chalcone,,DQFBYFPFKXHELB-VAWYXSNFSA-N
166,689043,caffeic acid,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Physiological Effects of Drugs;Protective Agents;Specialty Uses of Chemicals;Antioxidants;Chemical Actions and Uses,QAIPRVGONGVQAS-DUXPYHPUSA-N
167,5518,,,HRBUJQUHXGOSQW-UHFFFAOYSA-N
168,228398,,,DATAGRPVKZEWHA-UHFFFAOYSA-N
169,9817980,,,WTHURCRQFHKJKU-UHFFFAOYSA-N
170,442786,,,FSBUXLDOLNLABB-WZJPPVJYSA-N
171,10591,,,BHTRKEVKTKCXOH-XZWNYQJKSA-N
172,449005,Cardiolipins,,XVTUQDWPJJBEHJ-KZCWQMDCSA-N
173,71191,Cromakalim,Chemical Actions and Uses;Antihypertensive Agents;Physiological Effects of Drugs;Bronchodilator Agents;Vasodilator Agents;Autonomic Agents;Respiratory System Agents;Peripheral Nervous System Agents;Pharmacologic Actions;Parasympatholytics;Anti-Asthmatic Agents;Cardiovascular Agents;Therapeutic Uses,TVZCRIROJQEVOT-LSDHHAIUSA-N
174,5281771,echinacoside,,FSBUXLDOLNLABB-ISAKITKMSA-N
175,28558,beta-N-methylamino-L-alanine,Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Chemical Actions and Uses;Excitatory Amino Acid Agonists;Neurotransmitter Agents;Excitatory Amino Acid Agents,UJVHVMNGOZXSOZ-UHFFFAOYSA-N
176,673,dimethylglycine,,FFDGPVCHZBVARC-UHFFFAOYSA-N
177,1104,,,WWUZIQQURGPMPG-UHFFFAOYSA-N
178,4475,Nicergoline,Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Adrenergic Antagonists;Adrenergic Agents;Central Nervous System Agents;Therapeutic Uses;Adrenergic alpha-Antagonists;Cardiovascular Agents;Vasodilator Agents;Chemical Actions and Uses;Nootropic Agents;Pharmacologic Actions;Neurotransmitter Agents,YSEXMKHXIOCEJA-UHFFFAOYSA-N
179,24425,chromic acid,,KRVSOGSZCMJSLX-UHFFFAOYSA-L
180,25701,Cysteic Acid,,XVOYSCVBGLVSOL-UHFFFAOYSA-N
181,59708,Levetiracetam,Nootropic Agents;Pharmacologic Actions;Central Nervous System Agents;Chemical Actions and Uses;Therapeutic Uses;Anticonvulsants,HPHUVLMMVZITSG-UHFFFAOYSA-N
182,24480,manganese chloride,,GLFNIEUTAYBVOC-UHFFFAOYSA-L
183,92398,NSC 354646,,SXCIMUIAZXOVIR-PUCKCBAPSA-N
184,7189,,,DQFBYFPFKXHELB-UHFFFAOYSA-N
185,104798,,,PWYYWQHXAPXYMF-UHFFFAOYSA-N
186,667467,Chlorprothixene,Psychotropic Drugs;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Dopamine Agents;Chemical Actions and Uses;Central Nervous System Agents;Physiological Effects of Drugs;Central Nervous System Depressants;Dopamine Antagonists;Antipsychotic Agents;Tranquilizing Agents;Neurotransmitter Agents;Pharmacologic Actions,WSPOMRSOLSGNFJ-AUWJEWJLSA-N
187,29539,N-hydroxyphenacetin,,GPMYDZBSYQUDJZ-UHFFFAOYSA-N
188,442653,,,VABYUUZNAVQNPG-UHFFFAOYSA-N
189,439378,theanine,,DATAGRPVKZEWHA-YFKPBYRVSA-N
190,5960,Aspartic Acid,,CKLJMWTZIZZHCS-REOHCLBHSA-N
191,87379454,,,AVXZEYRIVAMKNG-UHFFFAOYSA-N
192,2012,Aconitine,"Immunologic Factors;Adjuvants, Immunologic;Chemical Actions and Uses;Voltage-Gated Sodium Channel Agonists;Molecular Mechanisms of Pharmacological Action;Membrane Transport Modulators;Physiological Effects of Drugs;Sodium Channel Agonists;Pharmacologic Actions",XFSBVAOIAHNAPC-UHFFFAOYSA-N
193,4364,,,PRQROPMIIGLWRP-UHFFFAOYSA-N
194,439177,Glycogen,,BYSGBSNPRWKUQH-UJDJLXLFSA-N
195,5283387,oleylamide,Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions;Food Ingredients;Central Nervous System Agents;Specialty Uses of Chemicals;Hypnotics and Sedatives;Food Additives;Physiological Effects of Drugs;Central Nervous System Depressants,FATBGEAMYMYZAF-KTKRTIGZSA-N
196,102399,,,FZWBNHMXJMCXLU-PPSBPDGWSA-N
197,71157,nefiracetam,Nootropic Agents;Physiological Effects of Drugs;Protective Agents;Central Nervous System Agents;Chemical Actions and Uses;Psychotropic Drugs;Pharmacologic Actions;Therapeutic Uses;Neuroprotective Agents,NGHTXZCKLWZPGK-UHFFFAOYSA-N
198,6328166,,,PBHCGFAQTBPLFW-UHFFFAOYSA-N
199,16683094,Triethyltin sulfate,,BTVURVLQSDTSSS-UHFFFAOYSA-L
200,709,,,KSEBMYQBYZTDHS-UHFFFAOYSA-N
201,1615,"N-Methyl-3,4-methylenedioxyamphetamine",Pharmacologic Actions;Adrenergic Agents;Psychotropic Drugs;Molecular Mechanisms of Pharmacological Action;Adrenergic Uptake Inhibitors;Hallucinogens;Central Nervous System Agents;Physiological Effects of Drugs;Membrane Transport Modulators;Therapeutic Uses;Neurotransmitter Uptake Inhibitors;Chemical Actions and Uses;Serotonin Agents;Neurotransmitter Agents,SHXWCVYOXRDMCX-UHFFFAOYSA-N
202,4812,Vitamin K 1,Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Hemostatics;Coagulants;Fibrin Modulating Agents;Therapeutic Uses;Growth Substances;Micronutrients;Vitamins;Hematologic Agents;Physiological Effects of Drugs;Nutrients;Pharmacologic Actions;Antifibrinolytic Agents,MBWXNTAXLNYFJB-UHFFFAOYSA-N
203,5470187,zerumbone,,GIHNTRQPEMKFKO-SKTNYSRSSA-N
204,64981,arctigenin,,NQWVSMVXKMHKTF-JKSUJKDBSA-N
205,6020,Puromycin Aminonucleoside,"Antimetabolites;Chemical Actions and Uses;Antibiotics, Antineoplastic;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Antimetabolites, Antineoplastic;Pharmacologic Actions;Noxae;Therapeutic Uses;Toxic Actions",RYSMHWILUNYBFW-GRIPGOBMSA-N
206,637394,hirsutanone,,VWHYFMQKJYFLCC-DUXPYHPUSA-N
207,24755482,,,NLSGUPWFZCWUGR-QVKCEAGUSA-N
208,637858,piperlonguminine,,VABYUUZNAVQNPG-BQYQJAHWSA-N
209,137,Aminolevulinic Acid,Photosensitizing Agents;Therapeutic Uses;Chemical Actions and Uses;Radiation-Sensitizing Agents;Dermatologic Agents;Pharmacologic Actions,ZGXJTSGNIOSYLO-UHFFFAOYSA-N
210,2477,Buspirone,Tranquilizing Agents;Chemical Actions and Uses;Therapeutic Uses;Physiological Effects of Drugs;Serotonin Agents;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Psychotropic Drugs;Central Nervous System Agents;Central Nervous System Depressants;Anti-Anxiety Agents;Serotonin Receptor Agonists;Neurotransmitter Agents,QWCRAEMEVRGPNT-UHFFFAOYSA-N
211,91195,"(1R,5S)-4-methyl-1-propan-2-ylbicyclo(3.1.0)hex-3-en-2-one",,LTTVJAQLCIHAFV-UHFFFAOYSA-N
212,4273754,JHW 015,"Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Pharmacologic Actions;Hormones, Hormone Substitutes, and Hormone Antagonists;Cannabinoid Receptor Agonists;Hormones;Cannabinoid Receptor Modulators;Chemical Actions and Uses;Physiological Effects of Drugs",LJSBBBWQTLXQEN-UHFFFAOYSA-N
213,69512,malvidin,,KQIKOUUKQBTQBE-UHFFFAOYSA-N
214,5280885,"9-deoxy-9,10-didehydro-12,13-didehydro-13,14-dihydroprostaglandin D2",Antiviral Agents;Antineoplastic Agents;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions;Anti-Infective Agents,TUXFWOHFPFBNEJ-GJGHEGAFSA-N
215,134071,KM 1146,,AUPNGGXXLZJAHC-UHFFFAOYSA-N
216,3910,leupeptin,Enzyme Inhibitors;Cysteine Proteinase Inhibitors;Chemical Actions and Uses;Protease Inhibitors;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action,GDBQQVLCIARPGH-UHFFFAOYSA-N
217,9964357,,,LTJBOUZUHSXYCG-UHFFFAOYSA-J
218,86664385,,,ABIGASPCHXKGDP-UHFFFAOYSA-N
219,6603977,5-(4-phenylbutoxy)psoralen,,JJAWGNIQEOFURP-UHFFFAOYSA-N
220,2866,,,BLGXFZZNTVWLAY-UHFFFAOYSA-N
221,768,Hydrogen Cyanide,Chemical Warfare Agents;Poisons;Specialty Uses of Chemicals;Chemical Actions and Uses;Toxic Actions;Noxae,LELOWRISYMNNSU-UHFFFAOYSA-N
222,2949,,,POZRVZJJTULAOH-UHFFFAOYSA-N
223,108018,N-chlorotaurine,Antiviral Agents;Anti-Infective Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Enzyme Inhibitors;Chemical Actions and Uses;Therapeutic Uses,NMMHHSLZJLPMEG-UHFFFAOYSA-N
224,387042,NSC 680410,,YJZSUCFGHXQWDM-UHFFFAOYSA-N
225,5725,zerumbone,,GIHNTRQPEMKFKO-UHFFFAOYSA-N
226,3036154,alpha-galactosylceramide,,VQFKFAKEUMHBLV-VDYNBUGPSA-N
227,160512,ar-turmerone,,NAAJVHHFAXWBOK-ZDUSSCGKSA-N
228,2545,,,DHZBEENLJMYSHQ-UHFFFAOYSA-N
229,11520587,"bis-1,3-((5,6-dihydro-5,11-diketo-11H-indeno(1,2-c)isoquinoline)-6-propylamino)propane",Chemical Actions and Uses;Therapeutic Uses;Topoisomerase I Inhibitors;Topoisomerase Inhibitors;Antineoplastic Agents;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,LFBROBFDCPLXOA-UHFFFAOYSA-N
230,6536812,ONO 1301,,WBBLIRPKRKYMTD-BYCLXTJYSA-N
231,6918876,,,FFXUDLUXUIJFSS-NTCAYCPXSA-N
232,253602,Anisomycin,Protein Synthesis Inhibitors;Molecular Mechanisms of Pharmacological Action;Nucleic Acid Synthesis Inhibitors;Chemical Actions and Uses;Antiprotozoal Agents;Enzyme Inhibitors;Anti-Infective Agents;Pharmacologic Actions;Therapeutic Uses;Anti-Bacterial Agents;Antiparasitic Agents,YKJYKKNCCRKFSL-RDBSUJKOSA-N
233,9975530,,,GMTJIWUFFXGFHH-RRROMXSMSA-N
234,2505,,,BLTCBVOJNNKFKC-UHFFFAOYSA-N
235,158796,N-(2-chlorophenylpropyl)-1-(3-methoxyphenyl)ethylamine,,YJXUXANREVNZLH-PFEQFJNWSA-N
236,114873,,,RZWIIPASKMUIAC-VQTJNVASSA-N
237,9857255,"2-((2'-amino)propionyl)aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid",,TWZDLCLCMKMJPE-OAOSNHGPSA-N
238,161557,ampelopsin,,KJXSIXMJHKAJOD-LSDHHAIUSA-N
239,54313,,,HIFJCPQKFCZDDL-NYBPDPFASA-N
240,115114,"2-(2,3-dicarboxycyclopropyl)glycine",Anticonvulsants;Central Nervous System Agents;Pharmacologic Actions;Therapeutic Uses;Chemical Actions and Uses,MATPZHBYOVDBLI-IDPZHQIBSA-N
241,5618,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Cardiovascular Agents;Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses;Vasoconstrictor Agents,LQANGKSBLPMBTJ-UHFFFAOYSA-N
242,10030106,,,BYTPMMJRDFCGKX-CZDRXDAJSA-N
243,3035635,1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid,,XSBZZZGVAIXJLD-UHFFFAOYSA-N
244,56841936,Kaolin,Antidiarrheals;Gastrointestinal Agents;Pharmacologic Actions;Therapeutic Uses;Chemical Actions and Uses,NLYAJNPCOHFWQQ-UHFFFAOYSA-N
245,44580018,,,BYTPMMJRDFCGKX-GJRFZWDISA-N
246,155773,Xamoterol,Adrenergic Agonists;Adrenergic beta-Agonists;Molecular Mechanisms of Pharmacological Action;Physiological Effects of Drugs;Adrenergic beta-1 Receptor Agonists;Chemical Actions and Uses;Pharmacologic Actions;Adrenergic Agents;Neurotransmitter Agents,QEDVGROSOZBGOZ-UHFFFAOYSA-N
247,2826713,KRN 7000,"Antineoplastic Agents;Therapeutic Uses;Chemical Actions and Uses;Immunologic Factors;Adjuvants, Immunologic;Physiological Effects of Drugs;Pharmacologic Actions",VQFKFAKEUMHBLV-BYSUZVQFSA-N
248,4248455,,,VCWLZDVWHQVAJU-UHFFFAOYSA-N
249,2142,,,LKCWBDHBTVXHDL-UHFFFAOYSA-N
250,189460,,,MGBKJKDRMRAZKC-UHFFFAOYSA-N
251,74493,,,CBOJBBMQJBVCMW-NQZVPSPJSA-N
252,,,,
253,5255,,,OPVPGKGADVGKTG-UHFFFAOYSA-N
254,309160,,,QMLSMSICNBXNLJ-UHFFFAOYSA-N
255,14180,Nicotinamide Mononucleotide,,DAYLJWODMCOQEW-TURQNECASA-N
256,5460037,Dextrans,Anticoagulants;Blood Substitutes;Plasma Substitutes;Pharmacologic Actions;Chemical Actions and Uses;Therapeutic Uses;Hematologic Agents,FZWBNHMXJMCXLU-BLAUPYHCSA-N
257,5281295,sulfuretin,,RGNXWPVNPFAADO-NSIKDUERSA-N
258,53399048,,,LSKCTKMTYNICJW-UHFFFAOYSA-N
259,2459,,,VUAFHZCUKUDDBC-UHFFFAOYSA-N
260,123871,6-hydroxydopa quinone,,YWRFBISQAMHSIX-YFKPBYRVSA-N
261,114827,eglumetad,Anti-Anxiety Agents;Excitatory Amino Acid Agents;Psychotropic Drugs;Central Nervous System Agents;Chemical Actions and Uses;Excitatory Amino Acid Agonists;Molecular Mechanisms of Pharmacological Action;Neurotransmitter Agents;Central Nervous System Depressants;Therapeutic Uses;Pharmacologic Actions;Tranquilizing Agents;Physiological Effects of Drugs,VTAARTQTOOYTES-UHFFFAOYSA-N
262,4972,,,AQTFKGDWFRRIHR-UHFFFAOYSA-L
263,11228183,ABT-737,,HPLNQCPCUACXLM-PGUFJCEWSA-N
264,17757205,,,ZDFOCDTXDPKJKA-WJOKGBTCSA-N
265,2826718,Caspofungin,Enzyme Inhibitors;Anti-Infective Agents;Therapeutic Uses;Pharmacologic Actions;Antifungal Agents;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,JYIKNQVWKBUSNH-OGZDCFRISA-N
266,91754599,,,HSOKCKRDVRKPGT-LLVKDONJSA-N
267,11725801,sauchinone,,GMTJIWUFFXGFHH-WPAOEJHSSA-N
268,153751,Aclarubicin,"Topoisomerase II Inhibitors;Antibiotics, Antineoplastic;Therapeutic Uses;Enzyme Inhibitors;Pharmacologic Actions;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Topoisomerase Inhibitors;Chemical Actions and Uses",KUSMIBXCRZTVML-PCCPLWKKSA-N
269,24287,stannic chloride,,HPGGPRDJHPYFRM-UHFFFAOYSA-J
270,9639,perflexane,,ZJIJAJXFLBMLCK-UHFFFAOYSA-N
271,242994,stevioside,Chemical Actions and Uses;Food Ingredients;Specialty Uses of Chemicals;Sweetening Agents;Flavoring Agents;Food Additives,UEDUENGHJMELGK-DROKWKKMSA-N
272,65684,dicarbine,Psychotropic Drugs;Specialty Uses of Chemicals;Physiological Effects of Drugs;Antioxidants;Chemical Actions and Uses;Central Nervous System Depressants;Therapeutic Uses;Antimutagenic Agents;Pharmacologic Actions;Toxic Actions;Molecular Mechanisms of Pharmacological Action;Tranquilizing Agents;Antipsychotic Agents;Cardiovascular Agents;Protective Agents;Anti-Arrhythmia Agents;Central Nervous System Agents;Teratogens;Noxae,CYJQCYXRNNCURD-UHFFFAOYSA-N
273,19065601,dinitrobenzenesulfonic acid,,IORISFYTXJVNFE-UHFFFAOYSA-N
274,5587,Tripelennamine,Therapeutic Uses;Chemical Actions and Uses;Physiological Effects of Drugs;Histamine Agents;Neurotransmitter Agents;Histamine Antagonists;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Histamine H1 Antagonists;Anti-Allergic Agents,UFLGIAIHIAPJJC-UHFFFAOYSA-N
275,105089,beta-N-methylamino-L-alanine,Chemical Actions and Uses;Excitatory Amino Acid Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Physiological Effects of Drugs;Neurotransmitter Agents;Excitatory Amino Acid Agonists,UJVHVMNGOZXSOZ-VKHMYHEASA-N
276,5291488,,,PEFNSGRTCBGNAN-UHFFFAOYSA-N
277,42948,"2,4,5,2',4',5'-hexabromobiphenyl",,HMBBJSKXDBUNNT-UHFFFAOYSA-N
278,65238,beta-penta-O-galloyl-glucose,,QJYNZEYHSMRWBK-NIKIMHBISA-N
279,23723,Erythrityl Tetranitrate,Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses;Cardiovascular Agents;Vasodilator Agents,SNFOERUNNSHUGP-UHFFFAOYSA-N
280,37768,Amikacin,Therapeutic Uses;Anti-Infective Agents;Anti-Bacterial Agents;Chemical Actions and Uses;Pharmacologic Actions,LKCWBDHBTVXHDL-RMDFUYIESA-N
281,5249,,,GFWRVVCDTLRWPK-UHFFFAOYSA-N
282,60846,Valsartan,Angiotensin II Type 1 Receptor Blockers;Chemical Actions and Uses;Pharmacologic Actions;Antihypertensive Agents;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Cardiovascular Agents;Angiotensin Receptor Antagonists,ACWBQPMHZXGDFX-QFIPXVFZSA-N
283,5282253,domoic acid,Chemical Actions and Uses;Neuromuscular Blocking Agents;Neuromuscular Agents;Physiological Effects of Drugs;Peripheral Nervous System Agents;Neuromuscular Depolarizing Agents;Pharmacologic Actions,VZFRNCSOCOPNDB-AOKDLOFSSA-N
284,2199,,,YKJYKKNCCRKFSL-UHFFFAOYSA-N
285,16158207,linaclotide,Molecular Mechanisms of Pharmacological Action;Enzyme Activators;Gastrointestinal Agents;Guanylyl Cyclase C Agonists;Chemical Actions and Uses;Therapeutic Uses;Pharmacologic Actions,KWFNVZFWXXEJKL-YZDVLOIKSA-N
286,12585,,,QMMOXUPEWRXHJS-UHFFFAOYSA-N
287,4993,Pyrimethamine,Pharmacologic Actions;Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Antimalarials;Antiprotozoal Agents;Antiparasitic Agents;Anti-Infective Agents;Therapeutic Uses;Folic Acid Antagonists,WKSAUQYGYAYLPV-UHFFFAOYSA-N
288,55466,Gadolinium DTPA,Specialty Uses of Chemicals;Chemical Actions and Uses;Contrast Media;Diagnostic Uses of Chemicals;Pharmacologic Actions,LGMLJQFQKXPRGA-VPVMAENOSA-K
289,287064,"methyl 3,4-dihydroxybenzoate",,CUFLZUDASVUNOE-UHFFFAOYSA-N
290,5281617,genkwanin,,JPMYFOBNRRGFNO-UHFFFAOYSA-N
291,5284583,Levetiracetam,Therapeutic Uses;Nootropic Agents;Chemical Actions and Uses;Pharmacologic Actions;Central Nervous System Agents;Anticonvulsants,HPHUVLMMVZITSG-LURJTMIESA-N
292,93091,titanium nitride,,NRTOMJZYCJJWKI-UHFFFAOYSA-N
293,93504,Cromakalim,Antihypertensive Agents;Therapeutic Uses;Bronchodilator Agents;Chemical Actions and Uses;Vasodilator Agents;Respiratory System Agents;Anti-Asthmatic Agents;Parasympatholytics;Cardiovascular Agents;Peripheral Nervous System Agents;Physiological Effects of Drugs;Autonomic Agents;Pharmacologic Actions,TVZCRIROJQEVOT-CABCVRRESA-N
294,5152,Salmeterol Xinafoate,Therapeutic Uses;Autonomic Agents;Molecular Mechanisms of Pharmacological Action;Anti-Asthmatic Agents;Chemical Actions and Uses;Bronchodilator Agents;Neurotransmitter Agents;Adrenergic beta-Agonists;Adrenergic Agents;Adrenergic beta-2 Receptor Agonists;Peripheral Nervous System Agents;Physiological Effects of Drugs;Pharmacologic Actions;Adrenergic Agonists;Respiratory System Agents,GIIZNNXWQWCKIB-UHFFFAOYSA-N
295,91516,ethylphenylpropiolate,,ACJOYTKWHPEIHW-UHFFFAOYSA-N
296,125105,"glycerophosphoinositol 4,5-bisphosphate",,VQSJAWPFQCXIOB-VODLGYORSA-N
297,11006,n-hexadecane,,DCAYPVUWAIABOU-UHFFFAOYSA-N
298,440735,eriodictyol,,SBHXYTNGIZCORC-ZDUSSCGKSA-N
299,67111,,,RGNXWPVNPFAADO-UHFFFAOYSA-N
300,10374453,,,MOTMGLITKDYJPL-UHFFFAOYSA-N
301,6223,Gliotoxin,Physiological Effects of Drugs;Immunologic Factors;Pharmacologic Actions;Immunosuppressive Agents;Chemical Actions and Uses,FIVPIPIDMRVLAY-RBJBARPLSA-N
302,9848818,tauroursodeoxycholic acid,Cholagogues and Choleretics;Antiviral Agents;Therapeutic Uses;Gastrointestinal Agents;Anti-Infective Agents;Pharmacologic Actions;Chemical Actions and Uses,BHTRKEVKTKCXOH-LBSADWJPSA-N
303,128016,HX 600,,DLFBCHSYAZBTSS-UHFFFAOYSA-N
304,311,Citric Acid,Sequestering Agents;Anticoagulants;Chemical Actions and Uses;Hematologic Agents;Specialty Uses of Chemicals;Calcium Chelating Agents;Therapeutic Uses;Chelating Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions,KRKNYBCHXYNGOX-UHFFFAOYSA-N
305,131350,saintopin,,CGFVUVWMYIHGHS-UHFFFAOYSA-N
306,1209,,,ASNFTDCKZKHJSW-UHFFFAOYSA-N
307,186,acetyl phosphate,,LIPOUNRJVLNBCD-UHFFFAOYSA-N
308,108001,"3,5-dihydroxyphenylglycine",Neurotransmitter Agents;Molecular Mechanisms of Pharmacological Action;Excitatory Amino Acid Antagonists;Pharmacologic Actions;Excitatory Amino Acid Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Excitatory Amino Acid Agonists,HOOWCUZPEFNHDT-UHFFFAOYSA-N
309,71315856,,,DPFYBZWSVVKNPZ-AQWIXGDGSA-N
310,61671,Vanadates,,IHIXIJGXTJIKRB-UHFFFAOYSA-N
311,24762199,,,LVTAJNYOAFOKTA-JMSWFPOCSA-N
312,442504,"(1R,5S)-4-methyl-1-propan-2-ylbicyclo(3.1.0)hex-3-en-2-one",,LTTVJAQLCIHAFV-WCBMZHEXSA-N
313,440038,,,BJOZNDRNJJZHPZ-LUWBGTNYSA-N
314,,,,
315,5354027,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Cardiovascular Agents;Therapeutic Uses;Pharmacologic Actions;Vasoconstrictor Agents;Chemical Actions and Uses,LQANGKSBLPMBTJ-RTYMFESYSA-N
316,1310,"1-amino-1,3-dicarboxycyclopentane",Pharmacologic Actions;Protective Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Neuroprotective Agents;Central Nervous System Agents,YFYNOWXBIBKGHB-UHFFFAOYSA-N
317,5355,Sulpiride,"Therapeutic Uses;Central Nervous System Depressants;Psychotropic Drugs;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Tranquilizing Agents;Antidepressive Agents, Second-Generation;Antidepressive Agents;Dopamine Antagonists;Antipsychotic Agents;Central Nervous System Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Dopamine Agents;Neurotransmitter Agents",BGRJTUBHPOOWDU-UHFFFAOYSA-N
318,3084046,sephadex,Laboratory Chemicals;Specialty Uses of Chemicals;Indicators and Reagents;Chemical Actions and Uses,BCPVZFFJGCURNR-OCOFDJSDSA-N
319,16132042,Alamethicin,Chemical Actions and Uses;Therapeutic Uses;Specialty Uses of Chemicals;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Membrane Transport Modulators;Anti-Infective Agents;Ionophores;Anti-Bacterial Agents;Pharmacologic Actions;Uncoupling Agents,LGHSQOCGTJHDIL-UTXLBGCNSA-N
320,67361,,,HXQVQGWHFRNKMS-UHFFFAOYSA-M
321,107985,triptolide,"Reproductive Control Agents;Physiological Effects of Drugs;Noxae;Immunosuppressive Agents;Molecular Mechanisms of Pharmacological Action;Antineoplastic Agents, Alkylating;Alkylating Agents;Pharmacologic Actions;Contraceptive Agents, Male;Chemical Actions and Uses;Toxic Actions;Immunologic Factors;Therapeutic Uses;Antispermatogenic Agents;Contraceptive Agents;Antineoplastic Agents",DFBIRQPKNDILPW-CIVMWXNOSA-N
322,15667210,,,XETARULVTCYJAN-XLPZGREQSA-N
323,3331970,"4-aminopyrrolidine-2,4-dicarboxylic acid",,XZFMJVJDSYRWDQ-UHFFFAOYSA-N
324,4914,Procaine,"Anesthetics, Local;Central Nervous System Agents;Anesthetics;Physiological Effects of Drugs;Peripheral Nervous System Agents;Central Nervous System Depressants;Pharmacologic Actions;Sensory System Agents;Chemical Actions and Uses;Therapeutic Uses",MFDFERRIHVXMIY-UHFFFAOYSA-N
325,16738692,,,GUBXYMKIJFOYOA-YMGPVYFXSA-N
326,114840,higenamine,"Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Hematologic Agents;Anti-Inflammatory Agents, Non-Steroidal;Fibrin Modulating Agents;Adrenergic Agents;Peripheral Nervous System Agents;Antirheumatic Agents;Sensory System Agents;Chemical Actions and Uses;Therapeutic Uses;Cardiovascular Agents;Adrenergic beta-Agonists;Analgesics;Anti-Inflammatory Agents;Specialty Uses of Chemicals;Neurotransmitter Agents;Physiological Effects of Drugs;Cardiotonic Agents;Protective Agents;Adrenergic Agonists;Analgesics, Non-Narcotic;Fibrinolytic Agents",WZRCQWQRFZITDX-UHFFFAOYSA-N
327,2803,Clonidine,Analgesics;Physiological Effects of Drugs;Adrenergic Agents;Chemical Actions and Uses;Adrenergic alpha-2 Receptor Agonists;Cardiovascular Agents;Adrenergic Agonists;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action;Antihypertensive Agents;Peripheral Nervous System Agents;Central Nervous System Agents;Sympatholytics;Autonomic Agents;Adrenergic alpha-Agonists;Neurotransmitter Agents;Sensory System Agents;Therapeutic Uses,GJSURZIOUXUGAL-UHFFFAOYSA-N
328,24766,Chondroitin Sulfates,,KXKPYJOVDUMHGS-OSRGNVMNSA-N
329,1599,Puromycin Aminonucleoside,"Therapeutic Uses;Antineoplastic Agents;Antibiotics, Antineoplastic;Antimetabolites;Noxae;Pharmacologic Actions;Toxic Actions;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Antimetabolites, Antineoplastic",RYSMHWILUNYBFW-UHFFFAOYSA-N
330,1574,2-methyl-5-HT,,WYWNEDARFVJQSG-UHFFFAOYSA-N
331,6597,Dichloroacetic Acid,,JXTHNDFMNIQAHM-UHFFFAOYSA-N
332,134018,Febuxostat,Gout Suppressants;Chemical Actions and Uses;Therapeutic Uses;Antirheumatic Agents;Pharmacologic Actions,BQSJTQLCZDPROO-UHFFFAOYSA-N
333,7276,styrene oxide,Carcinogens;Chemical Actions and Uses;Mutagens;Toxic Actions;Noxae,AWMVMTVKBNGEAK-UHFFFAOYSA-N
334,10198228,1-(2-pyrrolidinylcarbonyl)-2-pyrrolidinylboronic acid,,XSBZZZGVAIXJLD-YUMQZZPRSA-N
335,5944,Cantharidin,Specialty Uses of Chemicals;Pharmacologic Actions;Enzyme Inhibitors;Noxae;Irritants;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Toxic Actions,DHZBEENLJMYSHQ-XCVPVQRUSA-N
336,9815560,Streptokinase,Cardiovascular Agents;Fibrin Modulating Agents;Fibrinolytic Agents;Hematologic Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Therapeutic Uses;Chemical Actions and Uses,XRZWVSXEDRYQGC-UHFFFAOYSA-N
337,447782,,,YLIQVEPMZVVUEK-UHFFFAOYSA-O
338,11284169,sagopilone,Chemical Actions and Uses;Pharmacologic Actions;Therapeutic Uses;Antineoplastic Agents,BFZKMNSQCNVFGM-UCEYFQQTSA-N
339,656744,,,LELVHAQTWXTCLY-UHFFFAOYSA-N
340,5360515,Naltrexone,Central Nervous System Agents;Pharmacologic Actions;Peripheral Nervous System Agents;Physiological Effects of Drugs;Chemical Actions and Uses;Alcohol Deterrents;Sensory System Agents;Narcotic Antagonists;Therapeutic Uses,DQCKKXVULJGBQN-XFWGSAIBSA-N
341,12544,Glycochenodeoxycholic Acid,Specialty Uses of Chemicals;Surface-Active Agents;Detergents;Chemical Actions and Uses,GHCZAUBVMUEKKP-GYPHWSFCSA-N
342,251,,,RCNSAJSGRJSBKK-UHFFFAOYSA-N
343,6255462,4'-methoxyresveratrol,,IHVRWFJGOIWMGC-NSCUHMNNSA-N
344,3478,Glipizide,Hypoglycemic Agents;Chemical Actions and Uses;Pharmacologic Actions;Physiological Effects of Drugs,ZJJXGWJIGJFDTL-UHFFFAOYSA-N
345,6434544,"15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid",Pharmacologic Actions;Vasoconstrictor Agents;Therapeutic Uses;Cardiovascular Agents;Chemical Actions and Uses,LQANGKSBLPMBTJ-WTPHSRJXSA-N
346,3780,,,MOYKHGMNXAOIAT-UHFFFAOYSA-N
347,6883,Isosorbide Dinitrate,Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Pharmacologic Actions;Cardiovascular Agents;Vasodilator Agents;Nitric Oxide Donors;Therapeutic Uses,MOYKHGMNXAOIAT-JGWLITMVSA-N
348,2876,,,MZIOEPIEDDJOPP-UHFFFAOYSA-N
349,9937237,,,BFZKMNSQCNVFGM-UHFFFAOYSA-N
350,290380,,,ACEAELOMUCBPJP-UHFFFAOYSA-N
351,1930,oleylamide,Pharmacologic Actions;Chemical Actions and Uses;Food Additives;Physiological Effects of Drugs;Therapeutic Uses;Central Nervous System Agents;Central Nervous System Depressants;Food Ingredients;Hypnotics and Sedatives;Specialty Uses of Chemicals,FATBGEAMYMYZAF-UHFFFAOYSA-N
352,3675,Phenelzine,Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Antidepressive Agents;Monoamine Oxidase Inhibitors;Chemical Actions and Uses;Pharmacologic Actions;Enzyme Inhibitors;Psychotropic Drugs;Central Nervous System Agents,RMUCZJUITONUFY-UHFFFAOYSA-N
353,5462471,"Enkephalin, Ala(2)-MePhe(4)-Gly(5)-","Anti-Arrhythmia Agents;Narcotics;Analgesics;Cardiovascular Agents;Peripheral Nervous System Agents;Chemical Actions and Uses;Physiological Effects of Drugs;Therapeutic Uses;Molecular Mechanisms of Pharmacological Action;Central Nervous System Agents;Pharmacologic Actions;Analgesics, Opioid;Central Nervous System Depressants;Neurotransmitter Agents;Sensory System Agents",HPZJMUBDEAMBFI-WTNAPCKOSA-N
354,91466,matrine,,ZSBXGIUJOOQZMP-JLNYLFASSA-N
355,2578,Carmustine,"Toxic Actions;Antineoplastic Agents, Alkylating;Pharmacologic Actions;Antineoplastic Agents;Molecular Mechanisms of Pharmacological Action;Noxae;Alkylating Agents;Chemical Actions and Uses;Therapeutic Uses",DLGOEMSEDOSKAD-UHFFFAOYSA-N
356,46184563,,,JSTZMWXBGOXHSZ-CGHXCNIISA-N
357,5462310,,,OKTJSMMVPCPJKN-UHFFFAOYSA-N
358,213037,5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide,Enzyme Activators;Chemical Actions and Uses;Pharmacologic Actions;Molecular Mechanisms of Pharmacological Action,PQHLRGARXNPFCF-UHFFFAOYSA-N
359,9732,4-fluorophenol,,RHMPLDJJXGPMEX-UHFFFAOYSA-N
360,3016734,N-bromotaurine,,USAWSWBIFACPGD-UHFFFAOYSA-N
361,15487,denatonium,Aversive Agents;Molecular Mechanisms of Pharmacological Action;Chemical Actions and Uses;Specialty Uses of Chemicals;Physiological Effects of Drugs;Central Nervous System Agents;Peripheral Nervous System Agents;Therapeutic Uses;Abuse-Deterrent Formulations;Pharmaceutical Preparations;Pharmacologic Actions;Sensory System Agents;Pharmaceutic Aids,YNQALPDYZRNHNK-UHFFFAOYSA-N
362,11966249,Carrageenan,,ZNOZWUKQPJXOIG-XSBHQQIPSA-L
363,408895,,,YLWVQFBYKLFJMB-UHFFFAOYSA-N
364,3008868,dieckol,,DRZQFGYIIYNNEC-UHFFFAOYSA-N
365,5362129,Ramipril,Pharmacologic Actions;Cardiovascular Agents;Therapeutic Uses;Angiotensin-Converting Enzyme Inhibitors;Protease Inhibitors;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Antihypertensive Agents;Chemical Actions and Uses,HDACQVRGBOVJII-JBDAPHQKSA-N
366,10221200,,,QLZOWJNFLXSDSH-UHFFFAOYSA-N
367,9865515,mocetinostat,Enzyme Inhibitors;Pharmacologic Actions;Histone Deacetylase Inhibitors;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action,HRNLUBSXIHFDHP-UHFFFAOYSA-N
368,5358116,trimethyltin,,LYRCQNDYYRPFMF-UHFFFAOYSA-N
369,6850753,,,WHJKCPTVEYZNOG-UHFFFAOYSA-N
370,92396,tetcyclacis,,DPOWHSMECVNHAT-YERPJTIDSA-N
371,1352,1-(5-isoquinolinylsulfonyl)-3-methylpiperazine,Chemical Actions and Uses;Enzyme Inhibitors;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Protein Kinase Inhibitors,QGSCXAWTTISKLF-UHFFFAOYSA-N
372,154656,amediplase,,YQINXCSNGCDFCQ-CMOCDZPBSA-N
373,77319,,,FMDTUZFOCQKSFX-UHFFFAOYSA-N
374,72276,Catechin,,PFTAWBLQPZVEMU-UKRRQHHQSA-N
375,11524144,dorsomorphin,Protein Kinase Inhibitors;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Enzyme Inhibitors,XHBVYDAKJHETMP-UHFFFAOYSA-N
376,3365422,,,LQRZCSNQDRKLNN-UHFFFAOYSA-R
377,6437867,DDB,,YNPIDJWKKHGXAK-ADXGFCJISA-N
378,24812758,Canagliflozin,Chemical Actions and Uses;Hypoglycemic Agents;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Physiological Effects of Drugs;Sodium-Glucose Transporter 2 Inhibitors,XTNGUQKDFGDXSJ-ZXGKGEBGSA-N
379,34526,pirimiphos methyl,Pesticides;Toxic Actions;Chemical Actions and Uses;Insecticides;Specialty Uses of Chemicals;Agrochemicals,QHOQHJPRIBSPCY-UHFFFAOYSA-N
380,5038,,,HDACQVRGBOVJII-UHFFFAOYSA-N
381,4545574,,,JRQRKFDFHAPMGQ-UHFFFAOYSA-N
382,2729,Chlorprothixene,Antipsychotic Agents;Central Nervous System Depressants;Chemical Actions and Uses;Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Tranquilizing Agents;Dopamine Antagonists;Central Nervous System Agents;Physiological Effects of Drugs;Psychotropic Drugs;Therapeutic Uses;Dopamine Agents;Neurotransmitter Agents,WSPOMRSOLSGNFJ-UHFFFAOYSA-N
383,,,,
384,3033825,Simendan,Molecular Mechanisms of Pharmacological Action;Pharmacologic Actions;Cardiotonic Agents;Phosphodiesterase Inhibitors;Phosphodiesterase 3 Inhibitors;Specialty Uses of Chemicals;Enzyme Inhibitors;Vasodilator Agents;Protective Agents;Cardiovascular Agents;Therapeutic Uses;Chemical Actions and Uses,WHXMKTBCFHIYNQ-SECBINFHSA-N
